On June 28, 2024, the Supreme Court's decision in Loper Bright Enterprises v. Raimondo marked a significant shift by eliminating the Chevron doctrine, which for four decades had guided courts to defer to federal agencies' interpretations of unclear statutes. The Court ruled that this deference granted excessive interpretive power to the executive branch and conflicted with the Administrative Procedure Act (APA). Now, courts are required to independently evaluate whether an agency's actions align with the law, leading to a more rigorous review process. For healthcare providers, this could mean facing a more fluid regulatory landscape with increased litigation risks as courts independently interpret ERISA regulations without the previous deference to agency positions.